Home » Louis Drapeau

Louis Drapeau

Feb 22, 2007
Premium
Bio-Rad has appointed Louis Drapeau to the company’s board of directors.
 
Drapeau will also serve on the board’s audit committee.
 
He is currently CFO of Nektar Therapeutics, a drug-development firm that recently named former Sirna Therapeutics head Howard Robin as its president and CEO.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Lamar Alexander Won't Seek Re-Election

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

Second X Helping

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

Tracing the Bugs

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

This Week in PNAS

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.

What's Popular?

In Gene Silencing/Gene Editing

  1. Evogene, TMG Ink Pest-Resistant Soybean Development Deal

  2. ERS Genomics Licenses CRISPR Tech to Lonza

  3. Startup Firm Genetics Research Harnesses CRISPR for Sample Prep Technology

    Premium

  4. Genome Editing Patterns Could Help Predict CRISPR Outcomes

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.